In this webinar, InSphero CSO Prof. Armin Wolf will discuss how the research community gets “lost in translation” and share his strategy for bridging the divide between preclinical and clinical research to bring safe, effective drugs to market – and to patients in need of new therapeutics. Armin will introduce a “causality assay” framework for evaluating drug-induced liver injury (DILI) with novel 3D in vitro models and methodologies, and explain how multicellular 3D human liver spheroids can be used for investigating a broad range of experimental conditions using a variety of analytical methods, from liver enzyme markers and histological techniques to the latest ‘omics technologies. He'll also walk you through several examples of successful applications of causality assays for the deconvolution of major DILI mechanisms – and offer his vision for the future of 3D in vitro tools for translational liver toxicology – and beyond.

свернуть